Other Acute Pain Clinical Trial
Official title:
A Prospective, Open-label, Nonrandomized Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain
The purpose of this study is to determine the effectiveness, the safety, and the
tolerability of intranasal ketorolac (Sprix) in relieving acute pain in adults ages 18-64
who come to the ED seeking care. Considering all ED visits, pain is the most common chief
complaint. Giving intranasal ketorolac (Sprix) after stomach and dental surgeries has been
shown to be safe and effective, but no studies have investigated the use of intranasal
ketorolac (Sprix) for the treatment of acute pain in the ED.
Ketorolac (Sprix) has several advantages over other drugs commonly given for pain, including
opioids. Ketorolac (Sprix) is non-addicting and has fewer side effects than opioids. The
administration of ketorolac (Sprix) by other methods, such as IV, intramuscular shot, and
oral pill form, has been shown to be safe and effective in treating acute pain.
This study is being done to find out if giving ketorolac (Sprix) as a single dose nasal
spray will have the same benefit in decreasing patient's pain.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00802997 -
Trial Assessing Cooled Radiofrequency Denervation as a Treatment for Sacroiliac Joint Pain Using the Sinergy System
|
N/A | |
| Completed |
NCT01756651 -
Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures
|
Phase 1 | |
| Completed |
NCT01538745 -
Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department
|
Phase 4 |